1. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. Issue 3 (March 2022) Authors: Temesgen, Zelalem; Burger, Charles D; Baker, Jason; Polk, Christopher; Libertin, Claudia R; Kelley, Colleen F; Marconi, Vincent C; Orenstein, Robert; Catterson, Victoria M; Aronstein, William S; Durrant, Cameron; Chappell, Dale; Ahmed, Omar; Chappell, Gabrielle; Badley, Andrew D; Lewis, Meghan; S... Journal: Lancet Issue: Volume 10:Issue 3(2022) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗